Ryan Christopher Lennox - Net Worth and Insider Trading
Ryan Christopher Lennox Net Worth
The estimated net worth of Ryan Christopher Lennox is at least $1,600 dollars as of 2024-09-23. Ryan Christopher Lennox is the Senior Officer of HLS Therapeutics Inc and owns about 500 shares of HLS Therapeutics Inc (TSX:HLS) stock worth over $1,600. Details can be seen in Ryan Christopher Lennox's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ryan Christopher Lennox has not made any transactions after 2019-08-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ryan Christopher Lennox
Ryan Christopher Lennox Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ryan Christopher Lennox owns 1 companies in total, including HLS Therapeutics Inc (TSX:HLS) .
Click here to see the complete history of Ryan Christopher Lennox’s form 4 insider trades.
Insider Ownership Summary of Ryan Christopher Lennox
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:HLS | HLS Therapeutics Inc | 2019-08-30 | Senior Officer |
Ryan Christopher Lennox Latest Holdings Summary
Ryan Christopher Lennox currently owns a total of 1 stock. Ryan Christopher Lennox owns 500 shares of HLS Therapeutics Inc (TSX:HLS) as of August 30, 2019, with a value of $1,600.
Latest Holdings of Ryan Christopher Lennox
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:HLS | HLS Therapeutics Inc | 2019-08-30 | 500 | 3.20 | 1,600 |
Holding Weightings of Ryan Christopher Lennox
Ryan Christopher Lennox Form 4 Trading Tracker
According to the SEC Form 4 filings, Ryan Christopher Lennox has made a total of 0 transactions in HLS Therapeutics Inc (TSX:HLS) over the past 5 years. The most-recent trade in HLS Therapeutics Inc is the acquisition of 500 shares on August 30, 2019, which cost Ryan Christopher Lennox around $6,750.
Insider Trading History of Ryan Christopher Lennox
- 1
Ryan Christopher Lennox Trading Performance
GuruFocus tracks the stock performance after each of Ryan Christopher Lennox's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ryan Christopher Lennox is 28.93%. GuruFocus also compares Ryan Christopher Lennox's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ryan Christopher Lennox within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ryan Christopher Lennox's insider trading performs compared to the benchmark.
Performance of Ryan Christopher Lennox
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.21 | | | | | |
| Relative Return to S&P 500(%) | 5.49 | | | | | |
Ryan Christopher Lennox Ownership Network
Ryan Christopher Lennox Owned Company Details
What does HLS Therapeutics Inc do?
Who are the key executives at HLS Therapeutics Inc?
Ryan Christopher Lennox is the Senior Officer of HLS Therapeutics Inc. Other key executives at HLS Therapeutics Inc include Director & Senior Officer Craig Millian , Senior Officer Brian Thomas Walsh , and 10% Security Holder Polar Asset Management Partners Inc. .
HLS Therapeutics Inc (TSX:HLS) Insider Trades Summary
Over the past 18 months, Ryan Christopher Lennox made no insider transaction in HLS Therapeutics Inc (TSX:HLS). Other recent insider transactions involving HLS Therapeutics Inc (TSX:HLS) include a net purchase of 20,000 shares made by Tim Hendrickson , a net purchase of 12,500 shares made by Craig Millian , and a net purchase of 32,400 shares made by Polar Asset Management Partners Inc. .
In summary, during the past 3 months, insiders sold 0 shares of HLS Therapeutics Inc (TSX:HLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,300,000 shares of HLS Therapeutics Inc (TSX:HLS) were sold and 167,100 shares were bought by its insiders, resulting in a net sale of 1,132,900 shares.
HLS Therapeutics Inc (TSX:HLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
HLS Therapeutics Inc Insider Transactions
Ryan Christopher Lennox Mailing Address
Above is the net worth, insider trading, and ownership report for Ryan Christopher Lennox. Currently GuruFocus does not have mailing address information for Ryan Christopher Lennox.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
